Droplet microarray platforms for high-throughput drug screening

doi:10.1007/s00604-023-05833-9

Droplet microarray platforms for high-throughput drug screening

2023-06-15

12

PRE

AI

DOI：10.1007/s00604-023-05833-9

Original

Original request for help

Save

Abstract

En 中文

High-throughput screening platforms are fundamental for the rapid and efficient processing of large amounts of experimental data. Parallelization and miniaturization of experiments are important for improving their cost-effectiveness. The development of miniaturized high-throughput screening platforms is essential in the fields of biotechnology, medicine, and pharmacology. Currently, most laboratories use 96- or 384-well microtiter plates for screening; however, they have disadvantages, such as high reagent and cell consumption, low throughput, and inability to avoid cross-contamination, which need to be further optimized. Droplet microarrays, as novel screening platforms, can effectively avoid these shortcomings. Here, the preparation method of the droplet microarray, method of adding compounds in parallel, and means to read the results are briefly described. Next, the latest research on droplet microarray platforms in biomedicine is presented, including their application in high-throughput culture, cell screening, high-throughput nucleic acid screening, drug development, and individualized medicine. Finally, the challenges and future trends in droplet microarray technology are summarized.

Keywords:

Droplet microarray

High-throughput screening

Superhydrophobic-superhydrophilic pattern

Surface chemistry

Droplet microarray platforms for high-throughput drug screening

Abstract

Journal

Organization